Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: Cancer. 2009 Mar 15;115(6):1328. doi: 10.1002/cncr.24158

Table 1.

Patient history, management and outcome

Patient # Age (yrs) at first RFA Tumor Site of ablation # of lesions treated # lesion treatments (including repeat RFA) Post RFA -therapy Overall survival post first RFA (months)
1 33 synovial sarcoma lung 1 1 Off protocol RFA Chemotherapy 21
2 10 osteosarcoma lung 2 2 Radiotherapy 8
3 14 osteosarcoma lung 2 3 none 48*
4 12 osteosarcoma lung 4 4 Chemotherapy 12
5 18 osteosarcoma lung 3 3 Chemotherapy Cryotherapy 7
6 16 osteosarcoma lung 1 1 Chemotherapy Surgery 13
7 20 osteosarcoma lung 2 3 none 5
8 4 adrenocortical carcinoma lung 4 16 Chemotherapy Surgery 27
9 19 hepatocellular carcinoma liver 7 9 Chemotherapy Surgery 60**
21 lung 1 1
10 16 rhabdomyosarcoma breast 1 1 Chemo- 5
11 13 rhabdomyosarcoma maxilla 1 2 Chemotherapy 5
12 16 osteosarcoma lung 6 6 Chemotherapy Radiotherapy 12
16 radius 1 1
13 13 plantar fibromatosis feet 6 15 none 34**
14 10 Wilms tumor lung 9 9 Chemotherapy 33**
15 12 osteosarcoma lung 3 3 none 15
16 9 leiomyosarcoma ribs 2 2 Antiviral therapy 26**
*

Alive & well at end of study;

**

Alive with disease at end of study